MHPF (UK) LTD
Company number 10320006 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: MHPF (UK) LTD
1. Financial Health Score: C+ (Fair)
Grade explanation: MHPF (UK) LTD is solvent and benefits from a substantial property asset base, with all statutory filings up to date. However, its vital signs show weakened short-term liquidity, negative working capital, and a large bank loan falling due within the next 18 months. The business is asset-rich but cash-constrained, and accumulated losses are gradually eroding equity. On balance, the company is in fair condition but requires prompt attention to its refinancing and cash flow position to avoid a more serious decline.
2. Key Vital Signs
| Metric | Latest (2025) | Previous (2024) | Interpretation |
|---|---|---|---|
| Net assets | £26.94m | £28.09m | Positive equity, but down roughly 4% year-on-year. |
| Tangible fixed assets | £45.19m | £44.93m | Strong asset base, mainly freehold land and buildings. |
| Current assets | £1.47m | £1.03m | Improved, driven by higher cash, stock and debtors. |
| Current liabilities | £1.95m | £0.59m | More than tripled, mainly due to group borrowing and trade creditors. |
| Working capital (net current assets) | -£0.48m | +£0.44m | Negative: current liabilities exceed current assets. |
| Cash at bank | £0.47m | £0.29m | Improved, but only about 24% of current liabilities. |
| Long-term bank loan | £17.28m | £17.28m | Secured over land; repayable in full on 12 May 2027. |
| Connected company loan | £0.50m | Nil | Unsecured, matures 2030. |
| Amounts owed to group undertakings | £1.52m | £0.36m | Repayable on demand; included in current liabilities. |
| Approximate loss for the year | -£1.16m | – | Inferred from movement in profit and loss reserve. |
| Filing compliance | Up to date | Up to date | No overdue accounts or confirmation statements. |
What these numbers mean in plain terms: - Pulse (cash flow): Cash has risen, but the company is increasingly reliant on creditors rather than trading profits to fund operations. - Blood pressure (working capital): Negative working capital is a symptom of short-term strain—like hypotension, the business may struggle to meet immediate obligations without refinancing or asset sales. - Circulation (current ratio): At roughly 0.75, current assets cover only three-quarters of short-term debts. A healthy business typically aims for at least 1.0. - Skeleton (asset base): The property portfolio is the company’s strongest vital sign, providing substantial collateral and underlying value.
3. Diagnosis
Overall condition: Solvent but guarded. The company is not in immediate collapse, but it presents with several symptoms that, if untreated, could lead to serious distress.
Symptoms analysis: 1. Negative working capital: Current liabilities of £1.95m exceed current assets of £1.47m by £480k. This means the company does not have enough short-term assets to cover its short-term debts as they fall due. 2. Major debt maturity: The £17.28m secured bank loan is repayable in full on 12 May 2027. This is a large “bullet” repayment due within roughly 16–18 months of the last balance sheet date. If it cannot be refinanced or repaid, the lender could enforce its security over the company’s land. 3. Demand debt from group: £1.52m owed to group undertakings is repayable on demand, adding further short-term pressure. 4. Eroding reserves: The profit and loss reserve has moved from -£1.73m to -£2.89m, indicating an approximate operating loss of £1.16m for the year. Because the income statement is not filed under the small companies exemption, this is inferred from the balance sheet movement rather than reported directly. 5. Rising trade creditors: Trade creditors have increased from £64k to £201k, which may suggest suppliers are being paid more slowly.
Prognosis: The outlook is stable to cautious. The company’s land and property assets provide a strong foundation and significant security for lenders. If the bank loan is refinanced on acceptable terms and trading losses are addressed, the company can continue as a going concern. However, failure to refinance the £17.28m loan by May 2027, or a further increase in losses, would materially weaken the position and could force asset sales or restructuring. Continued reliance on demand debt from the group also introduces uncertainty.
4. Recommendations
- Prioritise refinancing of the bank loan: Begin discussions with the lender well before the 12 May 2027 maturity. Explore extending the loan term, converting part to a repayment mortgage, or arranging alternative funding to avoid a large lump-sum repayment.
- Strengthen working capital: Prepare a 13-week cash flow forecast to monitor the gap between current assets and current liabilities. Negotiate longer payment terms with suppliers where possible and accelerate collection of debtors.
- Address trading performance: Because the income statement is not publicly filed, management should produce monthly internal management accounts to identify the source of the £1.16m loss and take corrective action on costs or pricing in the mixed farming operation.
- Reduce reliance on demand debt: Review the £1.52m owed to group undertakings. Agree a repayment schedule or convert part to longer-term financing so it cannot be called at short notice.
- Maintain a cash buffer: Aim to hold cash equivalent to at least three months of operating costs to absorb unexpected expenses or interest rate changes (the loan carries interest at base rate plus 1.75%).
- Seek professional advice: Given the size of the secured debt and the connected company loans, the board should consult a financial adviser early if refinancing talks stall, to explore options before the position deteriorates.